Home/Filings/4/0001127602-25-006117
4//SEC Filing

Witherspoon Charles 4

Accession 0001127602-25-006117

CIK 0000105770other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 9:08 PM ET

Size

10.2 KB

Accession

0001127602-25-006117

Insider Transaction Report

Form 4
Period: 2025-02-18
Witherspoon Charles
VP & Treasurer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-18$211.00/sh+65.706$13,8641,318.847 total
  • Tax Payment

    Common Stock

    2025-02-18$211.00/sh23.492$4,9571,295.355 total
  • Award

    Stock Option (Right to Buy)

    2025-02-18+548548 total
    Exercise: $211.00From: 2026-02-18Exp: 2035-02-18Common Stock (548 underlying)
  • Award

    Rst. Stock Unit

    2025-02-18+237237 total
    Exercise: $0.00Common Stock (237 underlying)
Footnotes (1)
  • [F1]This award vests in four equal installments beginning on February 18, 2026.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001731739

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:08 PM ET
Size
10.2 KB